NCT03866109View on ClinicalTrials.gov

A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

December 9, 2025

Study Completion Date

December 9, 2025

Conditions
Glioblastoma Multiforme
Interventions
DRUG

Temferon

Genetically modified HSPCs

Trial Locations (3)

20132

ENROLLING_BY_INVITATION

Ospedale San Raffaele, Milan

20133

RECRUITING

"Fondazione IRCCS Istituto Neurologico Carlo Besta", Milan

Unknown

NOT_YET_RECRUITING

Policlinico Universitario Fondazione Agostino Gemelli, Rome

Sponsors

Lead Sponsor

Genenta Science
All Listed Sponsors
lead

Genenta Science

INDUSTRY

NCT03866109 - A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT | Biotech Hunter | Biotech Hunter